SCHEMBL21606074

SCHEMBL21606074

CCOC(=O)c1nn(CC)c(-c2cnc(Cl)cc2C)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.46
▸ RORC P51449 7/20 0.40
▸ PDE4A P27815 6/20 0.39
▸ PDE4B Q07343 6/20 0.39
▸ PDE4C Q08493 6/20 0.39
▸ PDE4D Q08499 6/20 0.39
▸ NPC1 O15118 3/20 0.37
▸ TP53 P04637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TLR9 Q9NR96 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21605722 0.90 KMT2A (0.43) KMT2ARORCPDE4APDE4BPDE4C
SCHEMBL21605622 0.88 RORC (0.45) RORC
SCHEMBL21605560 0.87 RORC (0.44) KMT2ARORCPDE4APDE4BPDE4C
SCHEMBL21606154 0.86 RORC (0.42) KMT2ARORC
SCHEMBL21605700 0.86 RORC (0.46) KMT2ARORC
SCHEMBL21605579 0.84 RORC (0.49) RORC
SCHEMBL21607462 0.81 ELANE (0.43) KMT2ARORCPDE4APDE4BPDE4C
SCHEMBL21606065 0.80 RORC (0.61) RORC
SCHEMBL21606032 0.78 FAAH (0.45) KMT2ATP53
SCHEMBL21605577 0.75 RORC (0.44) RORCALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3806958-B1 6-AMINOPYRIDIN-3-YL PYRAZOLES AS MODULATORS OF RORYT JANSSEN PHARMACEUTICA NV (BE) 2022-09-07 — — EP disclosed
US-10975057-B2 6-aminopyridin-3-yl pyrazoles as modulators of RORgT JANSSEN PHARMACEUTICA NV (BE) 2021-04-13 — — US disclosed
US-10975057-B2 6-aminopyridin-3-yl pyrazoles as modulators of RORgT JANSSEN PHARMACEUTICA NV (BE) 2021-04-13 — — US disclosed
CN-112292183-A 6-aminopyridin-3-yl-pyrazoles as modulators of ROR γ t 詹森药业有限公司 2021-01-29 — — CN disclosed
WO-2019244001-A1 6-AMINOPYRIDIN-3-YL PYRAZOLES AS MODULATORS OF RORYT JANSSEN PHARMACEUTICA NV (BE) 2019-12-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975057-B2 6-aminopyridin-3-yl pyrazoles as modulators of RORgT RORC, RORA, RORB KMT2A 878/4885RORC 1/4885PDE4A 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback